Hospital consolidation is a common practice, but its benefits can often be accomplished through other mechanisms, said Paul B. Ginsburg, PhD, the Leonard D. Schaeffer Chair in Health Policy Studies at the Brookings Institution and a professor of health policy at the University of Southern California.
Hospital consolidation is a common practice, but its benefits can often be accomplished through other mechanisms, said Paul B. Ginsburg, PhD, the Leonard D. Schaeffer Chair in Health Policy Studies at the Brookings Institution and a professor of health policy at the University of Southern California.
Transcript (slightly modified)
What is important for both payers and consumers to understand when it comes to hospital consolidation?
In a sense, they should be inclined against it and should be demanding of, well, what makes this consolidation different? I’m not saying that all consolidation is bad. Sometimes a hospital may be failing, may not be large enough to be viable, and consolidation is inevitable, either through a merger or through it disappearing from the market.
Certainly, consolidation is one of the tools where providers can better adapt to health IT requirements, reformed provider payments, but very often there are mechanisms short of a merger that can actually accomplish these things. There’s a lot, we call it virtual integration, just contractual relationships between various parties can often accomplish what is claimed as a benefit of consolidation.
How can hospital consolidation be done right?
Well, I think some of the biggest opportunities involve, for example, hospitals not employing physicians, but contracting with physician organizations to partner: partner for a new product, partner in an ACO contract with a health plan. And these potentially can work better, because physician leaders in say, medical groups or independent practice associations may be more successful in fostering changes in behavior by physicians that are needed to do well under reformed payments.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
How Mirdametinib Improves QOL for People With NF1-Associated Plexiform Neurofibromas
March 18th 2025Christopher L. Moertel, MD, University of Minnesota, discusses the trial data that helped get mirdametinib approved and what providers can do to keep measuring quality of life (QOL) improvements.
Read More
For Neuromuscular Disease Community, an Era of Opportunities and Threats
March 17th 2025Robert Califf, MD, former commissioner of the FDA, delivered a keynote address at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference that highlighted the enormous opportunities for progress in neuromuscular disease care amid a changing policy environment.
Read More